Analysts’ Revenue Estimates For Chembio Diagnostics, Inc. (NASDAQ:CEMI) Are Surging Higher

Shareholders in Chembio Diagnostics, Inc. (NASDAQ:CEMI) may be thrilled to learn that the analysts have just delivered a major upgrade to their near-term forecasts. The consensus estimated revenue numbers rose, with their view now clearly much more bullish…

Click here to view the original article.